Trinity Biotech (TRIB) Cash from Operations (2017 - 2024)
Trinity Biotech (TRIB) posted quarterly Cash from Operations of 3583000.0 for Q4 2024, up 1055.81% year-on-year from 310000.0 in Q1 2024, and up 191.5% on a QoQ basis from 3915683.0 in Q2 2024.
Trinity Biotech (TRIB) Cash from Operations (2017 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Cash from Operations for 6 consecutive years, with 3583000.0 the latest figure, recorded in Q4 2024.
- Quarterly Cash from Operations rose 1055.81% year-over-year to 3583000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 26000.0 (up 99.43% YoY) and the FY2025 annual result came in at 5929000.0, down 14.0% from the prior year.
- Cash from Operations advanced to 3583000.0 in Q4 2024 per TRIB's latest filing, from 3915683.0 in the prior quarter.
- Over the last five years, Cash from Operations for TRIB reached as high as 3910000.0 in Q4 2021 and fell as low as 7128695.0 in Q2 2023.
- A 4-year average of 120500.0 and a median of 153341.5 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 86.45% — and 2024, when it soared 1055.81%.
- Year by year, Cash from Operations stood at 3910000.0 in 2021, then plunged by 41.51% to 2287000.0 in 2022, then slumped by 86.45% to 310000.0 in 2023, then surged by 1055.81% to 3583000.0 in 2024.
- According to Business Quant data, Cash from Operations over the past three periods registered 3583000.0, 3915683.0, and 3317.0 for Q4 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.58 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Jun 30, 2024 | -3.92 Mn |
| Jun 30, 2024 | -3.92 Mn |
| Mar 31, 2024 | -3,317.00 |
| Mar 31, 2024 | -3,317.00 |
| Dec 31, 2023 | 310,000.00 |
| Dec 31, 2023 | 310,000.00 |
| Jun 30, 2023 | -7.13 Mn |
| Jun 30, 2023 | -7.13 Mn |
| Mar 31, 2023 | -6,305.00 |
| Mar 31, 2023 | -6,305.00 |
| Dec 31, 2022 | 2.29 Mn |
| Dec 31, 2022 | 2.29 Mn |
| Dec 31, 2021 | 3.91 Mn |
| Dec 31, 2021 | 3.91 Mn |
| Jun 30, 2018 | 1.74 Mn |
| Jun 30, 2018 | 1.74 Mn |
| Jun 30, 2017 | 3.37 Mn |
| Jun 30, 2017 | 3.37 Mn |